doi:10.16150/j.1671-2870.2020.05.005

Abstract

CLC Number:

R554

References 37

[1]	中华医学会呼吸病学分会肺栓塞与肺血管病学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会, 全国非栓塞与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南[J]. 中华医学杂志, 2018, 98(14):1060-1087.
[2]	《中国血栓性疾病防治指南》专家委员会. 中国血栓性疾病防治指南[J]. 中华医学杂志, 2018, 98(36):2861-2888.
[3]	Singh B, Parsaik AK, Agarwal D, et al. Diagnostic accuracy of pulmonary embolism rule-out criteria: a systema-tic review and meta-analysis[J]. Ann Emerg Med, 2012, 59(6):517-520,e1-e4. doi: 10.1016/j.annemergmed.2011.10.022 URL
[4]	Geersing GJ, Zuithoff NP, Kearon C, et al. Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis[J]. BMJ, 2014, 348:g1340. doi: 10.1136/bmj.g1340 URL
[5]	Bass AR, Fields KG, Goto R, et al. Clinical decision rules for pulmonary embolism in hospitalized patients: a systematic literature review and meta-analysis[J]. Thromb Haemost, 2017, 117(11):2176-2185. doi: 10.1160/TH17-06-0395 URL
[6]	Fabiá Valls MJ, van der Hulle T, den Exter PL, et al. Performance of a diagnostic algorithm based on a prediction rule, D-dimer and CT-scan for pulmonary embolism in patients with previous venous thromboembolism. A systematic review and meta-analysis[J]. Thromb Haemost, 2015, 113(2):406-413. doi: 10.1160/TH14-06-0488 URL
[7]	Schouten HJ, Geersing GJ, Koek HL, et al. Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis[J]. BMJ, 2013, 346:f2492. doi: 10.1136/bmj.f2492 URL
[8]	van Es N, van der Hulle T, van Es J, et al. Wells rule and d-Dimer testing to rule out pulmonary embolism: a systematic review and individual-patient data meta-analysis[J]. Ann Intern Med, 2016, 165(4):253-261. doi: 10.7326/M16-0031 URL
[9]	Righini M, van Es J, den Exter PL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study[J]. JAMA, 2014, 311(11):1117-1124. doi: 10.1001/jama.2014.2135 pmid: 24643601
[10]	Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism[J]. Eur Heart J, 2014, 35(43):3033-3069. doi: 10.1093/eurheartj/ehu283 pmid: 25173341
[11]	Wilts IT, Le Gal G, den Exter PL, et al. PO-29 - age-adjusted D-dimer cutoff level increases the number of cancer patients in who pulmonary embolism can be safely excluded without CT-PA imaging: The ADJUST-PE cancer substudy[J]. Thromb Res, 2016, 140(Suppl 1):S187.
[12]	Di Nisio M, Squizzato A, Rutjes AW, et al. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review[J]. J Thromb Haemost, 2007, 5(2):296-304. pmid: 17155963
[13]	Carrier M, Righini M, Djurabi RK, et al. VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism. A systematic review of management outcome studies[J]. Thromb Haemost, 2009, 101(5):886-892. doi: 10.1160/TH-08-10-0689 URL
[14]	Bates SM, Takach Lapner S, Douketis JD, et al. Rapid quantitative D-dimer to exclude pulmonary embolism: a prospective cohort management study[J]. J Thromb Haemost, 2016, 14(3):504-509. doi: 10.1111/jth.13234 pmid: 26707364
[15]	Clinical and Laboratory Standards Institute. Quantitative D-dimer for the exclusion of venous thromboembolism disease[R]. Approved guideline(H59-A), 31(6):15-17.
[16]	Kearon C, Akl EA, Ornelas J, et al. Antithrombotic the-rapy for VTE disease: CHEST Guideline and Expert Panel Report[J]. Chest, 2016, 149(2):315-352. doi: S0012-3692(15)00335-9 pmid: 26867832
[17]	Ulrych J, Kvasnicka T, Fryba V, et al. 28 day post-operative persisted hypercoagulability after surgery for benign diseases: a prospective cohort study[J]. BMC Surg, 2016, 16:16. doi: 10.1186/s12893-016-0128-3 pmid: 27048604
[18]	Kimura Y, Oki E, Ando K, et al. Incidence of venous thromboembolism following laparoscopic surgery for gastrointestinal cancer: a single-center, prospective cohort study[J]. World J Surg, 2016, 40(2):309-314. doi: 10.1007/s00268-015-3234-y pmid: 26316113
[19]	Kodama J, Seki N, Fukushima C, et al. Postoperative decreased levels of D-dimer in patients with gynecologic cancer with enoxaparin and fondaparinux thromboprophylaxis[J]. Mol Clin Oncol, 2013, 1(4):737-744. doi: 10.3892/mco.2013.120 URL
[20]	Lin Y, Liu Z, Qiu Y, et al. Clinical significance of plasma D-dimer and fibrinogen in digestive cancer: a systematic review and meta-analysis[J]. Eur J Surg Oncol, 2018, 44(10):1494-1503. doi: 10.1016/j.ejso.2018.07.052 URL
[21]	Li W, Tang Y, Song Y, et al. Prognostic role of pretreatment plasma D-Dimer in patients with solid tumors: a systematic review and meta-analysis[J]. Cell Physiol Biochem, 2018, 45(4):1663-1676. doi: 10.1159/000487734 URL
[22]	Simes J, Robledo KP, White HD, et al. D-dimer predicts long-term cause-specific mortality, cardiovascular events, and cancer in patients with stable coronary heart disease: LIPID study[J]. Circulation, 2018, 138(7):712-723. doi: 10.1161/CIRCULATIONAHA.117.029901 pmid: 29367425
[23]	Jara-Palomares L, Solier-Lopez A, Elias-Hernandez T, et al. D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis[J]. Br J Cancer, 2018, 119(8):915-921. doi: 10.1038/s41416-018-0269-5 URL
[24]	Ay C, Dunkler D, Marosi C, et al. Prediction of venous thromboembolism in cancer patients[J]. Blood, 2010, 116(24):5377-5382. doi: 10.1182/blood-2010-02-270116 URL
[25]	Bjøri E, Johnsen HS, Hansen JB, et al. D-dimer at venous thrombosis diagnosis is associated with risk of recurrence[J]. J Thromb Haemost, 2017, 15(5):917-924. doi: 10.1111/jth.13648 pmid: 28166605
[26]	Thaler J, Ay C, Pabinger I. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials[J]. Thromb Haemost, 2012, 108(6):1042-1048. doi: 10.1160/TH12-04-0241 URL
[27]	门剑龙, 钟殿胜, 任静. 血栓标志物评估恶性肿瘤患者静脉血栓风险[J]. 中华肿瘤杂志, 2015, 37(4):283-289.
[28]	Weitz JI, Fredenburgh JC, Eikelboom JW. A test in context: D-dimer[J]. J Am Coll Cardiol, 2017, 70(19):2411-2420. doi: 10.1016/j.jacc.2017.09.024 URL
[29]	Kearon C, Parpia S, Spencer FA, et al. Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; a cohort study[J]. J Thromb Haemost, 2019, 17(7):1144-1152. doi: 10.1111/jth.14458 pmid: 31033194
[30]	Zia A, Russell J, Sarode R, et al. Markers of coagulation activation, inflammation and fibrinolysis as predictors of poor outcomes after pediatric venous thromboembolism: a systematic review and meta-analysis[J]. Thromb Res, 2017, 160:1-8. doi: 10.1016/j.thromres.2017.10.003 URL
[31]	Johnson ED, Schell JC, Rodgers GM. The D-dimer assay[J]. Am J Hematol, 2019, 94(7):833-839. doi: 10.1002/ajh.25482 pmid: 30945756
[32]	Verhovsek M, Douketis JD, Yi Q, et al. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism[J]. Ann Intern Med, 2008, 149(7):481-490,W94. doi: 10.7326/0003-4819-149-7-200810070-00008 URL
[33]	Douketis J, Tosetto A, Marcucci M, et al. Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis[J]. BMJ, 2011, 342:d813. doi: 10.1136/bmj.d813 URL
[34]	Kearon C, Spencer FA, O'Keeffe D, et al. D-dimer tes-ting to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study[J]. Ann Intern Med, 2015, 162(1):27-34. doi: 10.7326/M14-1275 pmid: 25560712
[35]	Prandoni P, Vedovetto V, Ciammaichella M, et al. Resi-dual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis[J]. Thromb Res, 2017, 154:35-41. doi: S0049-3848(17)30256-6 pmid: 28407492
[36]	Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society(ERS)[J]. Eur Heart J, 2020, 41(4):543-603. doi: 10.1093/eurheartj/ehz405 pmid: 31504429
[37]	Morelli F, Schol-Gelok S, Arends LR, et al. Effect of antiplatelet drugs on D-dimer levels: a systematic review and meta-analysis[J]. J Cardiovasc Pharmacol, 2019, 73(6):343-351. doi: 10.1097/FJC.0000000000000670 URL

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 37

Related Articles 6

Recommended Articles

Metrics

Comments

[1]	FAN Zhenjia, LIU Yu, XU Guanqun, WU Wenman, WANG Xuefeng. The analysis of activities of vitamin K-dependent coagulation factors, protein C and protein S in patients on warfarin therapy [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(03): 362-366.
[2]	CAI Xiaoting, YI Huahua, LIN Jiayuan, CHEN Ling. Autosomal dominant polycystic kidney disease complicated with pulmonary embolism: a case report and literature review [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(01): 80-85.
[3]	LIANG Qian, LU Zhengjing, SHAO Yanyan, DING Qiulan, WANG Hongli, WANG Xuefeng. The application of thrombin generation test for assessing hemorrhagic tendency in patients with von Willebrand disease [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(04): 370-374.
[4]	JIN Peipei, LIANG Qian, DAI Jing, DING Qiulan, SUN Shunchang, WANG Xuefeng. Phenotype and genotype analysis of a Chinese pedigree with 2N type von Willebrand disease [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(02): 151-154.
[5]	LI Li, WANG Xiao, WANG Yao, KANG Jiang, ZHOU Luocheng, WANG Hairong. Expression of EGF-like domains of thrombomodulin domain 2(TM-D2) in Pichia pastoris [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(01): 55-59.
[6]	XIE Xiaoling, MA Siyu, WU Xi, LU Yeling, WANG Xuefeng, DING Qiulan. Molecular pathogenesis of two novel splice site mutations of F8 in hemophilia A [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(01): 32-37.